Skip to main content
Top
Published in: Arthritis Research & Therapy 5/2012

01-10-2012 | Review

Bone marrow edema and osteitis in rheumatoid arthritis: the imaging perspective

Author: Fiona M McQueen

Published in: Arthritis Research & Therapy | Issue 5/2012

Login to get access

Abstract

Magnetic resonance imaging bone marrow edema is an imaging feature that has been described in many conditions, including osteomyelitis, overuse syndromes, avascular necrosis, trauma, and inflammatory arthritides. In rheumatoid arthritis (RA), bone edema has special significance as it has been shown to be a common and widespread lesion that is often apparent at the hands and wrists but has also been described elsewhere, including the feet. It may occur in early or late disease and has been shown in several large cohort studies to have major negative implications for prognosis. It is the strongest predictor of erosive progression yet to be identified and characteristically occurs in those patients with the most aggressive and potentially disabling disease. In patients with undifferentiated arthritis, bone edema also predicts progression to criteria-positive RA, both independently and to a greater extent when combined with anti-cyclic citrullinated peptide status or rheumatoid factor positivity. Its histological correlate in the late stages of RA has been shown to be osteitis, in which the bone marrow beneath the joint is invaded by an inflammatory and vascular lymphoplasmacytic infiltrate. This lies adjacent to trabecular bone, where increased numbers of osteoclasts have been observed within resorption lacunae, suggesting a mechanistic link between inflammation and erosive bone damage. This could lead to erosion both of the overlying cortex, leading to classic radiographic rheumatoid erosions, and of local trabecular bone, possibly contributing to periarticular osteopenia and cyst formation. In addition to synovitis, osteitis is now regarded as a major rheumatoid lesion that is responsive to therapeutic intervention.
Appendix
Available only for authorised users
Literature
2.
go back to reference Resnick D, Gmelich JT: Bone fragmentation in the rheumatoid wrist: radiographic and pathologic considerations. Radiology. 1975, 114: 315-321.CrossRefPubMed Resnick D, Gmelich JT: Bone fragmentation in the rheumatoid wrist: radiographic and pathologic considerations. Radiology. 1975, 114: 315-321.CrossRefPubMed
3.
go back to reference Schett G, Firestein GS: Mr Outside and Mr Inside: classic and alternative views on the pathogenesis of rheumatoid arthritis. Ann Rheum Dis. 2010, 69: 787-789. 10.1136/ard.2009.121657.CrossRefPubMed Schett G, Firestein GS: Mr Outside and Mr Inside: classic and alternative views on the pathogenesis of rheumatoid arthritis. Ann Rheum Dis. 2010, 69: 787-789. 10.1136/ard.2009.121657.CrossRefPubMed
4.
go back to reference Wilson AJ, Murphy WA, Hardy DC, Totty WG: Transient osteoporosis: transient bone marrow edema?. Radiology. 1988, 167: 757-760.CrossRefPubMed Wilson AJ, Murphy WA, Hardy DC, Totty WG: Transient osteoporosis: transient bone marrow edema?. Radiology. 1988, 167: 757-760.CrossRefPubMed
5.
go back to reference Peterfy CG: Magnetic resonance imaging of the wrist in rheumatoid arthritis. Semin Musculoskelet Radiol. 2001, 5: 275-288. 10.1055/s-2001-17549.CrossRefPubMed Peterfy CG: Magnetic resonance imaging of the wrist in rheumatoid arthritis. Semin Musculoskelet Radiol. 2001, 5: 275-288. 10.1055/s-2001-17549.CrossRefPubMed
6.
go back to reference McQueen FM, Ostendorf B: What is MRI bone oedema in rheumatoid arthritis and why does it matter?. Arthritis Res Ther. 2006, 8: 222-225. 10.1186/ar2075.PubMedCentralCrossRefPubMed McQueen FM, Ostendorf B: What is MRI bone oedema in rheumatoid arthritis and why does it matter?. Arthritis Res Ther. 2006, 8: 222-225. 10.1186/ar2075.PubMedCentralCrossRefPubMed
7.
go back to reference Craig JG, Amin MB, Wu K, Eyler WR, van Holsbeeck MT, Bouffard JA, Shirazi K: Osteomyelitis of the diabetic foot: MR imaging-pathologic correlation. Radiology. 1997, 203: 849-855.CrossRefPubMed Craig JG, Amin MB, Wu K, Eyler WR, van Holsbeeck MT, Bouffard JA, Shirazi K: Osteomyelitis of the diabetic foot: MR imaging-pathologic correlation. Radiology. 1997, 203: 849-855.CrossRefPubMed
8.
go back to reference Poh YJ, Dalbeth N, Doyle A, McQueen FM: MRI bone oedema is not a major feature of gout unless there is concomitant osteomyelitis: ten year findings from a high prevalence population. J Rheumatol. 2011, 38: 2475-2481. 10.3899/jrheum.110477.CrossRefPubMed Poh YJ, Dalbeth N, Doyle A, McQueen FM: MRI bone oedema is not a major feature of gout unless there is concomitant osteomyelitis: ten year findings from a high prevalence population. J Rheumatol. 2011, 38: 2475-2481. 10.3899/jrheum.110477.CrossRefPubMed
9.
go back to reference Appel H, Loddenkemper C, Grozdanovic Z, Ebhardt H, Dreimann M, Hempfing A, Stein H, Metz-Stavenhagen P, Rudwaleit M, Sieper J: Correlation of histopathological findings and magnetic resonance imaging in the spine of patients with ankylosing spondylitis. Arthritis Res Ther. 2006, 8: R143-10.1186/ar2035.PubMedCentralCrossRefPubMed Appel H, Loddenkemper C, Grozdanovic Z, Ebhardt H, Dreimann M, Hempfing A, Stein H, Metz-Stavenhagen P, Rudwaleit M, Sieper J: Correlation of histopathological findings and magnetic resonance imaging in the spine of patients with ankylosing spondylitis. Arthritis Res Ther. 2006, 8: R143-10.1186/ar2035.PubMedCentralCrossRefPubMed
10.
go back to reference McQueen F, Lassere M, Ostergaard M: Magnetic resonance imaging in psoriatic arthritis: a review of the literature. Arthritis Res Ther. 2006, 8: 207-10.1186/ar1934.PubMedCentralCrossRefPubMed McQueen F, Lassere M, Ostergaard M: Magnetic resonance imaging in psoriatic arthritis: a review of the literature. Arthritis Res Ther. 2006, 8: 207-10.1186/ar1934.PubMedCentralCrossRefPubMed
11.
go back to reference Healy PJ, Groves C, Chandramohan M, Helliwell PS: MRI changes in psoriatic dactylitis - extent of pathology, relationship to tenderness and correlation with clinical indices. Rheumatology. 2008, 47: 92-95. 10.1093/rheumatology/kem315.CrossRefPubMed Healy PJ, Groves C, Chandramohan M, Helliwell PS: MRI changes in psoriatic dactylitis - extent of pathology, relationship to tenderness and correlation with clinical indices. Rheumatology. 2008, 47: 92-95. 10.1093/rheumatology/kem315.CrossRefPubMed
12.
go back to reference Tan YM, Østergaard M, Doyle A, Dalbeth N, Lobo M, Reeves Q, Robinson E, Taylor WJ, Jones PB, Pui K, Lee J, McQueen FM: MRI bone oedema scores are higher in the arthritis mutilans form of psoriatic arthritis and correlate with high radiographic scores for joint damage. Arthritis Res Ther. 2009, 11: R2-10.1186/ar2586.PubMedCentralCrossRefPubMed Tan YM, Østergaard M, Doyle A, Dalbeth N, Lobo M, Reeves Q, Robinson E, Taylor WJ, Jones PB, Pui K, Lee J, McQueen FM: MRI bone oedema scores are higher in the arthritis mutilans form of psoriatic arthritis and correlate with high radiographic scores for joint damage. Arthritis Res Ther. 2009, 11: R2-10.1186/ar2586.PubMedCentralCrossRefPubMed
13.
go back to reference Zanetti M, Bruder E, Romero J, Hodler J: Bone marrow edema pattern in osteoarthritic knees: correlation between MR imaging and histologic findings. Radiology. 2000, 215: 835-840.CrossRefPubMed Zanetti M, Bruder E, Romero J, Hodler J: Bone marrow edema pattern in osteoarthritic knees: correlation between MR imaging and histologic findings. Radiology. 2000, 215: 835-840.CrossRefPubMed
14.
go back to reference Taljanovic MS, Graham AR, Benjamin JB, Gmitro AF, Krupinski EA, Schwartz SA, Hunter TB, Resnick DL: Bone marrow edema pattern in advanced hip osteoarthritis: quantitative assessment with magnetic resonance imaging and correlation with clinical examination, radiographic findings, and histopathology. Skeletal Radiol. 2008, 37: 423-431. 10.1007/s00256-008-0446-3.CrossRefPubMed Taljanovic MS, Graham AR, Benjamin JB, Gmitro AF, Krupinski EA, Schwartz SA, Hunter TB, Resnick DL: Bone marrow edema pattern in advanced hip osteoarthritis: quantitative assessment with magnetic resonance imaging and correlation with clinical examination, radiographic findings, and histopathology. Skeletal Radiol. 2008, 37: 423-431. 10.1007/s00256-008-0446-3.CrossRefPubMed
15.
go back to reference Koenig H, Lucas D, Meissner R: The wrist: a preliminary report on high-resolution MR imaging. Radiology. 1986, 160: 463-467.CrossRefPubMed Koenig H, Lucas D, Meissner R: The wrist: a preliminary report on high-resolution MR imaging. Radiology. 1986, 160: 463-467.CrossRefPubMed
16.
go back to reference Jevtic V, Watt I, Rozman B, Kos-Golja M, Demsar F, Jarh O: Distinctive radiological features of small hand joints in rheumatoid arthritis and seronegative spondyloarthritis demonstrated by contrast-enhanced (Gd-DTPA) magnetic resonance imaging. Skeletal Radiol. 1995, 24: 351-355.CrossRefPubMed Jevtic V, Watt I, Rozman B, Kos-Golja M, Demsar F, Jarh O: Distinctive radiological features of small hand joints in rheumatoid arthritis and seronegative spondyloarthritis demonstrated by contrast-enhanced (Gd-DTPA) magnetic resonance imaging. Skeletal Radiol. 1995, 24: 351-355.CrossRefPubMed
17.
go back to reference McQueen FM, Stewart N, Crabbe J, Robinson E, Yeoman S, Tan PL, McLean L: Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals a high prevalence of erosions at four months after symptom onset. Ann Rheum Dis. 1998, 57: 350-356. 10.1136/ard.57.6.350.PubMedCentralCrossRefPubMed McQueen FM, Stewart N, Crabbe J, Robinson E, Yeoman S, Tan PL, McLean L: Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals a high prevalence of erosions at four months after symptom onset. Ann Rheum Dis. 1998, 57: 350-356. 10.1136/ard.57.6.350.PubMedCentralCrossRefPubMed
18.
go back to reference Peterfy CG, Countryman P, Gabriele A, Shaw T, Anisfeld A, Tsuji W, Olech E, Gaylis NB, Conaghan PG, Strand V, Dicarlo J: Magnetic resonance imaging in rheumatoid arthritis clinical trials: emerging patterns based on recent experience. J Rheumatol. 2011, 38: 2023-2030. 10.3899/jrheum.110418.CrossRefPubMed Peterfy CG, Countryman P, Gabriele A, Shaw T, Anisfeld A, Tsuji W, Olech E, Gaylis NB, Conaghan PG, Strand V, Dicarlo J: Magnetic resonance imaging in rheumatoid arthritis clinical trials: emerging patterns based on recent experience. J Rheumatol. 2011, 38: 2023-2030. 10.3899/jrheum.110418.CrossRefPubMed
19.
go back to reference Ostendorf B, Scherer A, Mödder U, Schneider M: Diagnostic value of magnetic resonance imaging of the forefeet in early rheumatoid arthritis when findings on imaging of the metacarpophalangeal joints of the hands remain normal. Arthritis Rheum. 2004, 50: 2094-2102. 10.1002/art.20314.CrossRefPubMed Ostendorf B, Scherer A, Mödder U, Schneider M: Diagnostic value of magnetic resonance imaging of the forefeet in early rheumatoid arthritis when findings on imaging of the metacarpophalangeal joints of the hands remain normal. Arthritis Rheum. 2004, 50: 2094-2102. 10.1002/art.20314.CrossRefPubMed
20.
go back to reference Savnik A, Malmskov H, Thomsen HS, Graff LB, Nielsen H, Danneskiold-Samsøe B, Boesen J, Bliddal H: Magnetic resonance imaging of the wrist and finger joints in patients with inflammatory joint diseases. J Rheumatol. 2001, 28: 2193-2200.PubMed Savnik A, Malmskov H, Thomsen HS, Graff LB, Nielsen H, Danneskiold-Samsøe B, Boesen J, Bliddal H: Magnetic resonance imaging of the wrist and finger joints in patients with inflammatory joint diseases. J Rheumatol. 2001, 28: 2193-2200.PubMed
21.
go back to reference Mundwiler ML, Maranian P, Brown DH, Silverman JM, Wallace D, Khanna D, Louie J, Furst DE, Weisman MH: The utility of MRI in predicting radiographic erosions in the metatarsophalangeal joints of the rheumatoid foot: a prospective longitudinal cohort study. Arthritis Res Ther. 2009, 11: R94-10.1186/ar2737.PubMedCentralCrossRefPubMed Mundwiler ML, Maranian P, Brown DH, Silverman JM, Wallace D, Khanna D, Louie J, Furst DE, Weisman MH: The utility of MRI in predicting radiographic erosions in the metatarsophalangeal joints of the rheumatoid foot: a prospective longitudinal cohort study. Arthritis Res Ther. 2009, 11: R94-10.1186/ar2737.PubMedCentralCrossRefPubMed
22.
go back to reference McQueen FM, Stewart N, Crabbe J, Robinson E, Yeoman S, Tan PL, McLean L: Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals progression of erosions despite clinical improvement. Ann Rheum Dis. 1999, 58: 156-163. 10.1136/ard.58.3.156.PubMedCentralCrossRefPubMed McQueen FM, Stewart N, Crabbe J, Robinson E, Yeoman S, Tan PL, McLean L: Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals progression of erosions despite clinical improvement. Ann Rheum Dis. 1999, 58: 156-163. 10.1136/ard.58.3.156.PubMedCentralCrossRefPubMed
23.
go back to reference McQueen FM, Benton N, Perry D, Crabbe J, Robinson E, Yeoman S, McLean L, Stewart N: Bone edema scored on magnetic resonance imaging scans of the dominant carpus at presentation predicts radiographic joint damage of the hands and feet six years later in patients with rheumatoid arthritis. Arthritis Rheum. 2003, 48: 1814-1827. 10.1002/art.11162.CrossRefPubMed McQueen FM, Benton N, Perry D, Crabbe J, Robinson E, Yeoman S, McLean L, Stewart N: Bone edema scored on magnetic resonance imaging scans of the dominant carpus at presentation predicts radiographic joint damage of the hands and feet six years later in patients with rheumatoid arthritis. Arthritis Rheum. 2003, 48: 1814-1827. 10.1002/art.11162.CrossRefPubMed
24.
go back to reference Zheng S, Robinson E, Yeoman S, Stewart N, Crabbe J, Rouse J, McQueen FM: MRI bone oedema predicts eight year tendon function at the wrist but not the requirement for orthopaedic surgery in rheumatoid arthritis. Ann Rheum Dis. 2006, 65: 607-611. 10.1136/ard.2005.043323.PubMedCentralCrossRefPubMed Zheng S, Robinson E, Yeoman S, Stewart N, Crabbe J, Rouse J, McQueen FM: MRI bone oedema predicts eight year tendon function at the wrist but not the requirement for orthopaedic surgery in rheumatoid arthritis. Ann Rheum Dis. 2006, 65: 607-611. 10.1136/ard.2005.043323.PubMedCentralCrossRefPubMed
25.
go back to reference McQueen FM, Benton N, Crabbe J, Robinson E, Yeoman S, McLean L, Stewart N: What is the fate of erosions in early rheumatoid arthritis? Tracking individual lesions using × rays and magnetic resonance imaging over the first two years of disease. Ann Rheum Dis. 2001, 60: 859-868.PubMedCentralPubMed McQueen FM, Benton N, Crabbe J, Robinson E, Yeoman S, McLean L, Stewart N: What is the fate of erosions in early rheumatoid arthritis? Tracking individual lesions using × rays and magnetic resonance imaging over the first two years of disease. Ann Rheum Dis. 2001, 60: 859-868.PubMedCentralPubMed
26.
go back to reference van der Heijde DM, van Riel PL, Nuver-Zwart IH, Gribnau FW, vad de Putte LB: Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis. Lancet. 1989, 1: 1036-1038.CrossRefPubMed van der Heijde DM, van Riel PL, Nuver-Zwart IH, Gribnau FW, vad de Putte LB: Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis. Lancet. 1989, 1: 1036-1038.CrossRefPubMed
27.
go back to reference Benton N, Stewart N, Crabbe J, Robinson E, Yeoman S, McQueen FM: MRI of the wrist in early rheumatoid arthritis can be used to predict functional outcome at 6 years. Ann Rheum Dis. 2004, 63: 555-561. 10.1136/ard.2003.011544.PubMedCentralCrossRefPubMed Benton N, Stewart N, Crabbe J, Robinson E, Yeoman S, McQueen FM: MRI of the wrist in early rheumatoid arthritis can be used to predict functional outcome at 6 years. Ann Rheum Dis. 2004, 63: 555-561. 10.1136/ard.2003.011544.PubMedCentralCrossRefPubMed
28.
go back to reference Haavardsholm EA, Bøyesen P, Østergaard M, Schildvold A, Kvien TK: Magnetic resonance imaging findings in 84 patients with early rheumatoid arthritis: bone marrow oedema predicts erosive progression. Ann Rheum Dis. 2008, 67: 794-800. 10.1136/ard.2007.071977.CrossRefPubMed Haavardsholm EA, Bøyesen P, Østergaard M, Schildvold A, Kvien TK: Magnetic resonance imaging findings in 84 patients with early rheumatoid arthritis: bone marrow oedema predicts erosive progression. Ann Rheum Dis. 2008, 67: 794-800. 10.1136/ard.2007.071977.CrossRefPubMed
29.
go back to reference Hetland ML, Ejbjerg B, Hørslev-Petersen K, Jacobsen S, Vestergaard A, Jurik AG, Stengaard-Pedersen K, Junker P, Lottenburger T, Hansen I, Andersen LS, Tarp U, Skjødt H, Pedersen JK, Majgaard O, Svendsen AJ, Ellingsen T, Lindegaard H, Christensen AF, Vallø J, Torfing T, Narvestad E, Thomsen HS, Ostergaard M, CIMESTRA study group: MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA). Ann Rheum Dis. 2009, 68: 384-390. 10.1136/ard.2008.088245.CrossRefPubMed Hetland ML, Ejbjerg B, Hørslev-Petersen K, Jacobsen S, Vestergaard A, Jurik AG, Stengaard-Pedersen K, Junker P, Lottenburger T, Hansen I, Andersen LS, Tarp U, Skjødt H, Pedersen JK, Majgaard O, Svendsen AJ, Ellingsen T, Lindegaard H, Christensen AF, Vallø J, Torfing T, Narvestad E, Thomsen HS, Ostergaard M, CIMESTRA study group: MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA). Ann Rheum Dis. 2009, 68: 384-390. 10.1136/ard.2008.088245.CrossRefPubMed
30.
go back to reference Hetland ML, Stengaard-Pedersen K, Junker P, Østergaard M, Ejbjerg BJ, Jacobsen S, Lottenburger T, Hansen I, Tarp U, Andersen LS, Svendsen A, Pedersen JK, Lauridsen UB, Ellingsen T, Lindegaard H, Pødenphant J, Vestergaard A, Jurik AG, Hørslev-Petersen K, CIMESTRA study group: Radiographic progression and remission rates in early rheumatoid arthritis - MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial. Ann Rheum Dis. 2010, 69: 1789-1795. 10.1136/ard.2009.125534.CrossRefPubMed Hetland ML, Stengaard-Pedersen K, Junker P, Østergaard M, Ejbjerg BJ, Jacobsen S, Lottenburger T, Hansen I, Tarp U, Andersen LS, Svendsen A, Pedersen JK, Lauridsen UB, Ellingsen T, Lindegaard H, Pødenphant J, Vestergaard A, Jurik AG, Hørslev-Petersen K, CIMESTRA study group: Radiographic progression and remission rates in early rheumatoid arthritis - MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial. Ann Rheum Dis. 2010, 69: 1789-1795. 10.1136/ard.2009.125534.CrossRefPubMed
31.
go back to reference Østergaard M, Peterfy C, Conaghan P, McQueen F, Bird P, Ejbjerg B, Shnier R, O'Connor P, Klarlund M, Emery P, Genant H, Lassere M, Edmonds J: OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring system. J Rheumatol. 2003, 30: 1385-1386.PubMed Østergaard M, Peterfy C, Conaghan P, McQueen F, Bird P, Ejbjerg B, Shnier R, O'Connor P, Klarlund M, Emery P, Genant H, Lassere M, Edmonds J: OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring system. J Rheumatol. 2003, 30: 1385-1386.PubMed
32.
go back to reference Hetland ML, Stengaard-Pedersen K, Junker P, Lottenburger T, Hansen I, Andersen LS, Tarp U, Svendsen A, Pedersen JK, Skjødt H, Lauridsen UB, Ellingsen T, Hansen GV, Lindegaard H, Vestergaard A, Jurik AG, Østergaard M, Hørslev-Petersen K, CIMESTRA study group: Aggressive combination therapy with intra-articular glucocorticoid injections and conventional disease-modifying anti-rheumatic drugs in early rheumatoid arthritis: second-year clinical and radiographic results from the CIMESTRA study. Ann Rheum Dis. 2008, 67: 815-822. 10.1136/ard.2007.076307.CrossRefPubMed Hetland ML, Stengaard-Pedersen K, Junker P, Lottenburger T, Hansen I, Andersen LS, Tarp U, Svendsen A, Pedersen JK, Skjødt H, Lauridsen UB, Ellingsen T, Hansen GV, Lindegaard H, Vestergaard A, Jurik AG, Østergaard M, Hørslev-Petersen K, CIMESTRA study group: Aggressive combination therapy with intra-articular glucocorticoid injections and conventional disease-modifying anti-rheumatic drugs in early rheumatoid arthritis: second-year clinical and radiographic results from the CIMESTRA study. Ann Rheum Dis. 2008, 67: 815-822. 10.1136/ard.2007.076307.CrossRefPubMed
33.
go back to reference Palosaari K, Vuotila J, Takalo R, Jartti A, Niemelä RK, Karjalainen A, Haapea M, Soini I, Tervonen O, Hakala M: Bone oedema predicts erosive progression on wrist MRI in early RA--a 2-yr observational MRI and NC scintigraphy study. Rheumatology. 2006, 45: 1542-1548. 10.1093/rheumatology/kel137.CrossRefPubMed Palosaari K, Vuotila J, Takalo R, Jartti A, Niemelä RK, Karjalainen A, Haapea M, Soini I, Tervonen O, Hakala M: Bone oedema predicts erosive progression on wrist MRI in early RA--a 2-yr observational MRI and NC scintigraphy study. Rheumatology. 2006, 45: 1542-1548. 10.1093/rheumatology/kel137.CrossRefPubMed
34.
go back to reference Bøyesen P, Haavardsholm EA, van der Heijde D, Østergaard M, Hammer HB, Sesseng S, Kvien TK: Prediction of MRI erosive progression: a comparison of modern imaging modalities in early rheumatoid arthritis patients. Ann Rheum Dis. 2011, 70: 176-179. 10.1136/ard.2009.126953.CrossRefPubMed Bøyesen P, Haavardsholm EA, van der Heijde D, Østergaard M, Hammer HB, Sesseng S, Kvien TK: Prediction of MRI erosive progression: a comparison of modern imaging modalities in early rheumatoid arthritis patients. Ann Rheum Dis. 2011, 70: 176-179. 10.1136/ard.2009.126953.CrossRefPubMed
35.
go back to reference Savnik A, Bliddal H, Nyengaard JR, Thomsen HS: MRI of the arthritic finger joints: synovial membrane volume determination, a manual vs a stereologic method. Eur Radiol. 2002, 12: 94-98. 10.1007/s003300100986.CrossRefPubMed Savnik A, Bliddal H, Nyengaard JR, Thomsen HS: MRI of the arthritic finger joints: synovial membrane volume determination, a manual vs a stereologic method. Eur Radiol. 2002, 12: 94-98. 10.1007/s003300100986.CrossRefPubMed
36.
go back to reference Duer-Jensen A, Hørslev-Petersen K, Hetland ML, Bak L, Ejbjerg BJ, Hansen MS, Johansen JS, Lindegaard HM, Vinterberg H, Møller JM, Østergaard M: Bone edema on magnetic resonance imaging is an independent predictor of rheumatoid arthritis development in patients with early undifferentiated arthritis. Arthritis Rheum. 2011, 63: 2192-2202. 10.1002/art.30396.CrossRefPubMed Duer-Jensen A, Hørslev-Petersen K, Hetland ML, Bak L, Ejbjerg BJ, Hansen MS, Johansen JS, Lindegaard HM, Vinterberg H, Møller JM, Østergaard M: Bone edema on magnetic resonance imaging is an independent predictor of rheumatoid arthritis development in patients with early undifferentiated arthritis. Arthritis Rheum. 2011, 63: 2192-2202. 10.1002/art.30396.CrossRefPubMed
37.
go back to reference Tamai K Yamato M, Yamaguchi T, Ohno W: Bone marrow oedema determined by MRI reflects severe disease status in patients with early-stage rheumatoid arthritis. Ann Rheum Dis. 2006, 65 (Suppl II): 629- Tamai K Yamato M, Yamaguchi T, Ohno W: Bone marrow oedema determined by MRI reflects severe disease status in patients with early-stage rheumatoid arthritis. Ann Rheum Dis. 2006, 65 (Suppl II): 629-
38.
go back to reference Tamai M, Kawakami A, Uetani M, Takao S, Arima K, Iwamoto N, Fujikawa K, Aramaki T, Kawashiri SY, Ichinose K, Kamachi M, Nakamura H, Origuchi T, Ida H, Aoyagi K, Eguchi K: A prediction rule for disease outcome in patients with undifferentiated arthritis using magnetic resonance imaging of the wrists and finger joints and serologic autoantibodies. Arthritis Rheum. 2009, 61: 772-778. 10.1002/art.24711.CrossRefPubMed Tamai M, Kawakami A, Uetani M, Takao S, Arima K, Iwamoto N, Fujikawa K, Aramaki T, Kawashiri SY, Ichinose K, Kamachi M, Nakamura H, Origuchi T, Ida H, Aoyagi K, Eguchi K: A prediction rule for disease outcome in patients with undifferentiated arthritis using magnetic resonance imaging of the wrists and finger joints and serologic autoantibodies. Arthritis Rheum. 2009, 61: 772-778. 10.1002/art.24711.CrossRefPubMed
39.
go back to reference Conaghan PG, O'Connor P, McGonagle D, Astin P, Wakefield RJ, Gibbon WW, Quinn M, Karim Z, Green MJ, Proudman S, Isaacs J, Emery P: Elucidation of the relationship between synovitis and bone damage: a randomized magnetic resonance imaging study of individual joints in patients with early rheumatoid arthritis. Arthritis Rheum. 2003, 48: 64-71. 10.1002/art.10747.CrossRefPubMed Conaghan PG, O'Connor P, McGonagle D, Astin P, Wakefield RJ, Gibbon WW, Quinn M, Karim Z, Green MJ, Proudman S, Isaacs J, Emery P: Elucidation of the relationship between synovitis and bone damage: a randomized magnetic resonance imaging study of individual joints in patients with early rheumatoid arthritis. Arthritis Rheum. 2003, 48: 64-71. 10.1002/art.10747.CrossRefPubMed
40.
go back to reference Conaghan PG, Emery P, Østergaard M, Keystone EC, Genovese MC, Hsia EC, Xu W, Rahman MU: Assessment by MRI of inflammation and damage in rheumatoid arthritis patients with methotrexate inadequate response receiving golimumab: results of the GO-FORWARD trial. Ann Rheum Dis. 2011, 70: 1968-1974. 10.1136/ard.2010.146068.PubMedCentralCrossRefPubMed Conaghan PG, Emery P, Østergaard M, Keystone EC, Genovese MC, Hsia EC, Xu W, Rahman MU: Assessment by MRI of inflammation and damage in rheumatoid arthritis patients with methotrexate inadequate response receiving golimumab: results of the GO-FORWARD trial. Ann Rheum Dis. 2011, 70: 1968-1974. 10.1136/ard.2010.146068.PubMedCentralCrossRefPubMed
41.
go back to reference Taylor PC, Steuer A, Gruber J, Cosgrove DO, Blomley MJ, Marsters PA, Wagner CL, McClinton C, Maini RN: Comparison of ultrasonographic assessment of synovitis and joint vascularity with radiographic evaluation in a randomized, placebo-controlled study of infliximab therapy in early rheumatoid arthritis. Arthritis Rheum. 2004, 50: 1107-1116. 10.1002/art.20123.CrossRefPubMed Taylor PC, Steuer A, Gruber J, Cosgrove DO, Blomley MJ, Marsters PA, Wagner CL, McClinton C, Maini RN: Comparison of ultrasonographic assessment of synovitis and joint vascularity with radiographic evaluation in a randomized, placebo-controlled study of infliximab therapy in early rheumatoid arthritis. Arthritis Rheum. 2004, 50: 1107-1116. 10.1002/art.20123.CrossRefPubMed
42.
go back to reference Naredo E, Möller I, Cruz A, Carmona L, Garrido J: Power Doppler ultrasonographic monitoring of response to anti-tumor necrosis factor therapy in patients with rheumatoid arthritis. Arthritis Rheum. 2008, 58: 2248-2256. 10.1002/art.23682.CrossRefPubMed Naredo E, Möller I, Cruz A, Carmona L, Garrido J: Power Doppler ultrasonographic monitoring of response to anti-tumor necrosis factor therapy in patients with rheumatoid arthritis. Arthritis Rheum. 2008, 58: 2248-2256. 10.1002/art.23682.CrossRefPubMed
43.
go back to reference Brown AK, Conaghan PG, Karim Z, Quinn MA, Ikeda K, Peterfy CG, Hensor E, Wakefield RJ, O'Connor PJ, Emery P: An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum. 2008, 58: 2958-2967. 10.1002/art.23945.CrossRefPubMed Brown AK, Conaghan PG, Karim Z, Quinn MA, Ikeda K, Peterfy CG, Hensor E, Wakefield RJ, O'Connor PJ, Emery P: An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum. 2008, 58: 2958-2967. 10.1002/art.23945.CrossRefPubMed
44.
go back to reference Boesen M, Ellegaard K, Boesen L, Cimmino MA, Jensen PS, Terslev L, Torp-Pedersen S, Danneskiold-Samsøe B, Bliddal H: Ultrasound Doppler score correlates with OMERACT RAMRIS bone marrow oedema and synovitis score in the wrist joint of patients with rheumatoid arthritis. Ultraschall Med. 2011. Boesen M, Ellegaard K, Boesen L, Cimmino MA, Jensen PS, Terslev L, Torp-Pedersen S, Danneskiold-Samsøe B, Bliddal H: Ultrasound Doppler score correlates with OMERACT RAMRIS bone marrow oedema and synovitis score in the wrist joint of patients with rheumatoid arthritis. Ultraschall Med. 2011.
45.
go back to reference Hodgson R, Grainger A, O'Connor P, Barnes T, Connolly S, Moots R: Dynamic contrast enhanced MRI of bone marrow oedema in rheumatoid arthritis. Ann Rheum Dis. 2008, 67: 270-272. 10.1136/ard.2007.077271.CrossRefPubMed Hodgson R, Grainger A, O'Connor P, Barnes T, Connolly S, Moots R: Dynamic contrast enhanced MRI of bone marrow oedema in rheumatoid arthritis. Ann Rheum Dis. 2008, 67: 270-272. 10.1136/ard.2007.077271.CrossRefPubMed
46.
go back to reference McQueen FM, Gao A, Ostergaard M, King A, Shalley G, Robinson E, Doyle A, Clark B, Dalbeth N: High grade MRI bone oedema is common within the surgical field in rheumatoid arthritis patients undergoing joint replacement and is associated with osteitis in subchondral bone. Ann Rheum Dis. 2007, 66: 1581-1587. 10.1136/ard.2007.070326.PubMedCentralCrossRefPubMed McQueen FM, Gao A, Ostergaard M, King A, Shalley G, Robinson E, Doyle A, Clark B, Dalbeth N: High grade MRI bone oedema is common within the surgical field in rheumatoid arthritis patients undergoing joint replacement and is associated with osteitis in subchondral bone. Ann Rheum Dis. 2007, 66: 1581-1587. 10.1136/ard.2007.070326.PubMedCentralCrossRefPubMed
47.
go back to reference McQueen F, Clarke A, McHaffie A, Reeves Q, Williams M, Robinson E, Dong J, Chand A, Mulders D, Dalbeth N: Assessment of cartilage loss at the wrist in rheumatoid arthritis using a new MRI scoring system. Ann Rheum Dis. 2010, 69: 1971-1975. 10.1136/ard.2009.127324.CrossRefPubMed McQueen F, Clarke A, McHaffie A, Reeves Q, Williams M, Robinson E, Dong J, Chand A, Mulders D, Dalbeth N: Assessment of cartilage loss at the wrist in rheumatoid arthritis using a new MRI scoring system. Ann Rheum Dis. 2010, 69: 1971-1975. 10.1136/ard.2009.127324.CrossRefPubMed
48.
go back to reference van der Heijde D: Erosions versus joint space narrowing in rheumatoid arthritis: what do we know?. Ann Rheum Dis. 2011, 70 (Suppl 1): i116-118. 10.1136/ard.2010.140525.CrossRefPubMed van der Heijde D: Erosions versus joint space narrowing in rheumatoid arthritis: what do we know?. Ann Rheum Dis. 2011, 70 (Suppl 1): i116-118. 10.1136/ard.2010.140525.CrossRefPubMed
49.
go back to reference Jimenez-Boj E, Nöbauer-Huhmann I, Hanslik-Schnabel B, Dorotka R, Wanivenhaus AH, Kainberger F, Trattnig S, Axmann R, Tsuji W, Hermann S, Smolen J, Schett G: Bone erosions and bone marrow edema as defined by magnetic resonance imaging reflect true bone marrow inflammation in rheumatoid arthritis. Arthritis Rheum. 2007, 56: 1118-1124. 10.1002/art.22496.CrossRefPubMed Jimenez-Boj E, Nöbauer-Huhmann I, Hanslik-Schnabel B, Dorotka R, Wanivenhaus AH, Kainberger F, Trattnig S, Axmann R, Tsuji W, Hermann S, Smolen J, Schett G: Bone erosions and bone marrow edema as defined by magnetic resonance imaging reflect true bone marrow inflammation in rheumatoid arthritis. Arthritis Rheum. 2007, 56: 1118-1124. 10.1002/art.22496.CrossRefPubMed
50.
go back to reference Dalbeth N, Smith T, Gray S, Doyle A, Antill P, Lobo M, Robinson E, King A, Cornish J, Shalley G, Gao A, McQueen FM: Cellular characterisation of magnetic resonance imaging bone oedema in rheumatoid arthritis; implications for pathogenesis of erosive disease. Ann Rheum Dis. 2009, 68: 279-282. 10.1136/ard.2008.096024.CrossRefPubMed Dalbeth N, Smith T, Gray S, Doyle A, Antill P, Lobo M, Robinson E, King A, Cornish J, Shalley G, Gao A, McQueen FM: Cellular characterisation of magnetic resonance imaging bone oedema in rheumatoid arthritis; implications for pathogenesis of erosive disease. Ann Rheum Dis. 2009, 68: 279-282. 10.1136/ard.2008.096024.CrossRefPubMed
51.
go back to reference McQueen F: A B cell explanation for autoimmune disease: the forbidden clone returns. Postgrad Med J. 2012, 88: 226-233. 10.1136/postgradmedj-2011-130364.CrossRefPubMed McQueen F: A B cell explanation for autoimmune disease: the forbidden clone returns. Postgrad Med J. 2012, 88: 226-233. 10.1136/postgradmedj-2011-130364.CrossRefPubMed
52.
53.
go back to reference Hoff M, Haugeberg G, Odegård S, Syversen S, Landewé R, van der Heijde D, Kvien TK: Cortical hand bone loss after 1 year in early rheumatoid arthritis predicts radiographic hand joint damage at 5-year and 10-year follow-up. Ann Rheum Dis. 2009, 68: 324-329. 10.1136/ard.2007.085985.CrossRefPubMed Hoff M, Haugeberg G, Odegård S, Syversen S, Landewé R, van der Heijde D, Kvien TK: Cortical hand bone loss after 1 year in early rheumatoid arthritis predicts radiographic hand joint damage at 5-year and 10-year follow-up. Ann Rheum Dis. 2009, 68: 324-329. 10.1136/ard.2007.085985.CrossRefPubMed
54.
go back to reference de Rooy DP, Kälvesten J, Huizinga TW, van der Helm-van Mil AH: Loss of metacarpal bone density predicts RA development in recent-onset arthritis. Rheumatology. 2012, 51: 1037-1041. 10.1093/rheumatology/ker435.CrossRefPubMed de Rooy DP, Kälvesten J, Huizinga TW, van der Helm-van Mil AH: Loss of metacarpal bone density predicts RA development in recent-onset arthritis. Rheumatology. 2012, 51: 1037-1041. 10.1093/rheumatology/ker435.CrossRefPubMed
55.
go back to reference Shimizu S, Shiozawa S, Shiozawa K, Imura S, Fujita T: Quantitative histologic studies on the pathogenesis of periarticular osteoporosis in rheumatoid arthritis. Arthritis Rheum. 1985, 28: 25-31. 10.1002/art.1780280105.CrossRefPubMed Shimizu S, Shiozawa S, Shiozawa K, Imura S, Fujita T: Quantitative histologic studies on the pathogenesis of periarticular osteoporosis in rheumatoid arthritis. Arthritis Rheum. 1985, 28: 25-31. 10.1002/art.1780280105.CrossRefPubMed
56.
go back to reference Goldring SR, Gravallese EM: Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications. Arthritis Res. 2000, 2: 33-37. 10.1186/ar67.PubMedCentralCrossRefPubMed Goldring SR, Gravallese EM: Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications. Arthritis Res. 2000, 2: 33-37. 10.1186/ar67.PubMedCentralCrossRefPubMed
57.
go back to reference Døhn UM, Ejbjerg B, Boonen A, Hetland ML, Hansen MS, Knudsen LS, Hansen A, Madsen OR, Hasselquist M, Møller JM, Ostergaard M: No overall progression and occasional repair of erosions despite persistent inflammation in adalimumab-treated rheumatoid arthritis patients: results from a longitudinal comparative MRI, ultrasonography, CT and radiography study. Ann Rheum Dis. 2011, 70: 252-258. 10.1136/ard.2009.123729.CrossRefPubMed Døhn UM, Ejbjerg B, Boonen A, Hetland ML, Hansen MS, Knudsen LS, Hansen A, Madsen OR, Hasselquist M, Møller JM, Ostergaard M: No overall progression and occasional repair of erosions despite persistent inflammation in adalimumab-treated rheumatoid arthritis patients: results from a longitudinal comparative MRI, ultrasonography, CT and radiography study. Ann Rheum Dis. 2011, 70: 252-258. 10.1136/ard.2009.123729.CrossRefPubMed
58.
go back to reference McQueen F, Naredo E: The 'disconnect' between synovitis and erosion in rheumatoid arthritis: a result of treatment or intrinsic to the disease process itself?. Ann Rheum Dis. 2011, 70: 241-244. 10.1136/ard.2010.139535.CrossRefPubMed McQueen F, Naredo E: The 'disconnect' between synovitis and erosion in rheumatoid arthritis: a result of treatment or intrinsic to the disease process itself?. Ann Rheum Dis. 2011, 70: 241-244. 10.1136/ard.2010.139535.CrossRefPubMed
59.
go back to reference Sato K, Takayanagi H: Osteoclasts, rheumatoid arthritis, and osteoimmunology. Curr Opin Rheumatol. 2006, 18: 419-426. 10.1097/01.bor.0000231912.24740.a5.CrossRefPubMed Sato K, Takayanagi H: Osteoclasts, rheumatoid arthritis, and osteoimmunology. Curr Opin Rheumatol. 2006, 18: 419-426. 10.1097/01.bor.0000231912.24740.a5.CrossRefPubMed
60.
go back to reference Cohen SB, Dore RK, Lane NE, Ory PA, Peterfy CG, Sharp JT, van der Heijde D, Zhou L, Tsuji W, Newmark R, Denosumab Rheumatoid Arthritis Study Group: Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial. Arthritis Rheum. 2008, 58: 1299-1309. 10.1002/art.23417.CrossRefPubMed Cohen SB, Dore RK, Lane NE, Ory PA, Peterfy CG, Sharp JT, van der Heijde D, Zhou L, Tsuji W, Newmark R, Denosumab Rheumatoid Arthritis Study Group: Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial. Arthritis Rheum. 2008, 58: 1299-1309. 10.1002/art.23417.CrossRefPubMed
61.
go back to reference Peterfy C, Emery P, Tak PP, Østergaard M, DiCarlo J, Otsa K, Navarro Sarabi F, Pavelka K, Preston K, Shaw T, Bagnard MA, Gabriele A: Rituximab (RTX) plus methotrexate (MTX) prevents bone erosion and joint space narrowing (jsn) and reduces synovitis, osteitis as shown on MRI: results from a randomised, placebo-controlled clinical trial on patients with rheumatoid arthritis (RA-score) [abstract]. Ann Rheum Dis. 2011, 70 (Suppl 3): 152- Peterfy C, Emery P, Tak PP, Østergaard M, DiCarlo J, Otsa K, Navarro Sarabi F, Pavelka K, Preston K, Shaw T, Bagnard MA, Gabriele A: Rituximab (RTX) plus methotrexate (MTX) prevents bone erosion and joint space narrowing (jsn) and reduces synovitis, osteitis as shown on MRI: results from a randomised, placebo-controlled clinical trial on patients with rheumatoid arthritis (RA-score) [abstract]. Ann Rheum Dis. 2011, 70 (Suppl 3): 152-
62.
go back to reference Tak PP, Rigby WF, Rubbert-Roth A, Peterfy CG, van Vollenhoven RF, Stohl W, Hessey E, Chen A, Tyrrell H, Shaw TM, IMAGE Investigators: Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial. Ann Rheum Dis. 2011, 70: 39-46. 10.1136/ard.2010.137703.CrossRefPubMed Tak PP, Rigby WF, Rubbert-Roth A, Peterfy CG, van Vollenhoven RF, Stohl W, Hessey E, Chen A, Tyrrell H, Shaw TM, IMAGE Investigators: Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial. Ann Rheum Dis. 2011, 70: 39-46. 10.1136/ard.2010.137703.CrossRefPubMed
63.
go back to reference Boumans MJ, Thurlings RM, Yeo L, Scheel-Toellner D, Vos K, Gerlag DM, Tak PP: Rituximab abrogates joint destruction in rheumatoid arthritis by inhibiting osteoclastogenesis. Ann Rheum Dis. 2012, 71: 108-113. 10.1136/annrheumdis-2011-200198.CrossRefPubMed Boumans MJ, Thurlings RM, Yeo L, Scheel-Toellner D, Vos K, Gerlag DM, Tak PP: Rituximab abrogates joint destruction in rheumatoid arthritis by inhibiting osteoclastogenesis. Ann Rheum Dis. 2012, 71: 108-113. 10.1136/annrheumdis-2011-200198.CrossRefPubMed
64.
go back to reference Troum OM, Peterfy CG, Kaine JL, Chung CA, Olech E, Conaghan PG: Baseline CRP predicts early improvement in synovitis, osteitis, and erosion on MRI in RA patients treated with tocilizumab: results from the ACT-RAY MRI substudy. Arthritis Rheum. 2010, 62 (Suppl 10): 120- Troum OM, Peterfy CG, Kaine JL, Chung CA, Olech E, Conaghan PG: Baseline CRP predicts early improvement in synovitis, osteitis, and erosion on MRI in RA patients treated with tocilizumab: results from the ACT-RAY MRI substudy. Arthritis Rheum. 2010, 62 (Suppl 10): 120-
65.
go back to reference Peterfy C, Durez P, DiCarlo J, Becker JC, Vratsanos G, Overfield S, Qi K: Abatacept reduces osteitis and inhibits bone erosion in anti-CCP2 positive patients with synovitis at high risk of developing RA. Arthritis Rheum. 2009, 60 (Suppl 10): 1690- Peterfy C, Durez P, DiCarlo J, Becker JC, Vratsanos G, Overfield S, Qi K: Abatacept reduces osteitis and inhibits bone erosion in anti-CCP2 positive patients with synovitis at high risk of developing RA. Arthritis Rheum. 2009, 60 (Suppl 10): 1690-
Metadata
Title
Bone marrow edema and osteitis in rheumatoid arthritis: the imaging perspective
Author
Fiona M McQueen
Publication date
01-10-2012
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 5/2012
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar4035

Other articles of this Issue 5/2012

Arthritis Research & Therapy 5/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.